An upbeat tone is seeping into markets as investors dig into Nvidia's quarterly earnings beat, which signaled plenty of scope ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

According to Bloomberg News, a $590 million contract awarded to Modern by the U.S. government to aid in vaccine development ...

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) was scheduled for 13th March and was ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

Nvidia said sales, driven by the chips that power artificial intelligence, rose 78% to $39.3 billion in its latest quarter. Net income rose 80% to $22 billion. Both figures came in ahead of Wall ...

Last year, the administration of former President Joe Biden allocated more than $800 million to combat bird flu in livestock.

Eli Lilly plans to invest $27 billion in new U.S. plants amidst threats of drug import tariffs by the Trump administration.